High rates of obesity among middle-aged Black women with HIV in UK cohort
Further evidence that recycling tenofovir in second-line treatment is effective
Asian people with HIV gain weight after starting treatment at similar rate to other ethnic groups
Persistent and worsening obesity seen in young people on lifelong antiretroviral treatment
Greater weight gain in pregnancy linked to TAF-and-integrase inhibitor combinations
Large US study confirms that people switching from TDF to TAF experience rising blood fat levels
People with HIV taking newer antiretrovirals at higher risk of fatty liver disease
Older version of tenofovir used as PrEP linked to weight loss
Weight gain after changing treatment more likely when switching from efavirenz or old-style tenofovir